Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FSKE4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,369
Award facts
- Contract value 100% obligated
- $2,368.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On November 14, 2025, the Defense Logistics Agency awarded a delivery order valued at $2,368.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The delivery order is issued under a firm fixed-price structure with an ultimate completion date of December 8, 2025. This award carries no set-aside designation, reflecting the vendor's competitive capability in unrestricted federal procurement. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare operations worldwide. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with structured base and option periods to enable the supply of branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities globally. DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors under this strategic framework, with no subcontractors identified in this transaction.
Quick answers
Who was awarded contract SPE2DR26FSKE4?
SPE2DR26FSKE4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FSKE4 worth?
The government has obligated $2,369 on SPE2DR26FSKE4.
Is contract SPE2DR26FSKE4 an order under another contract?
Yes. SPE2DR26FSKE4 is a delivery order under SPE2DR25D9317, an indefinite delivery contract.
Was contract SPE2DR26FSKE4 competed?
The extent of competition for SPE2DR26FSKE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award